ARGIPAC

PHARMACEUTICAL PREPARATIONS, NAMELY, PREPARATIONS FOR INTRAVENOUS ADMINISTRATION FOR THE TREATMENT OF STROKES; PHARMACEUTICAL PREPARATIONS, NAMELY, PREPARATIONS FOR TREATMENT OF STROKES; PHARMACEUTICAL PREPARATIONS, NAMELY, PREPARATIONS FOR TREATMENT OF PATIENTS WHO HAVE OR ARE AT HIGH RISK FOR HAVING ATHEROSCLEROSIS, HIGH CHOLESTEROL, HYPER-LIPIDEMIA, PULMONARY EDEMA, NEUROLOGICAL DISORDERS, CARDIO-VASCULAR DISEASE, CEREBRAL VASCULAR ACCIDENTS, OR APOPLEXY; AND MEDICATIONS FOR THE TREATMENT OF STOKES; PHARMACEUTICAL PREPARATIONS, NAMELY, L-ARGININE PREPARATIONS FOR INTRAVENOUS ADMINISTRATION FOR THE TREATMENT OF STROKES